Ritlecitinib effectively reduces psychosocial burden in severe alopecia areata, beyond hair regrowth benefits. Significant improvements in emotional symptoms and activity limitations were observed ...
Nektar Therapeutics is expected to announce topline data from the REZOLVE-AA trial in December 2025. The Food and Drug Administration (FDA) has granted Fast Track designation to rezpegaldesleukin for ...
For many people, alopecia areata presents as small, well-defined patches of hair loss on the scalp. But for others with severe cases, the unpredictable autoimmune disease can progress to a complete ...
Please provide your email address to receive an email when new articles are posted on . Rezpegaldesleukin is an interleukin-2 receptor pathway agonist that may stimulate regulatory T-cell expansion ...
Credit: SUN Pharma. Leqselvi is supplied as a tablet containing 8mg of deuruxolitinib. Prior to initiating treatment with Leqselvi, certain evaluations and immunizations are recommended. Leqselvi ™ ...
The FDA approved the oral Janus kinase (JAK) inhibitor deuruxolitinib (Leqselvi) to treat alopecia areata, drugmaker Sun Pharmaceutical announced on Thursday. The approval stipulates use of ...
Please provide your email address to receive an email when new articles are posted on . By week 152, 80% of patients who were withdrawn from baricitinib therapy lost their hair again vs. only 7% of ...
Baricitinib showed significant hair regrowth in adolescents with severe alopecia areata, with 71% achieving successful scalp regrowth at 52 weeks on a 4 mg dose. The study highlighted the importance ...
Hair loss caused by alopecia areata now has a new FDA-approved treatment, a third-in-class drug from Sun Pharmaceutical Industries that will compete against commercialized medicines from Eli Lilly and ...
The Manual on MSN
Experiencing hair loss on GLP-1? Expert tips to manage it
Most things in life come with tradeoffs, but sometimes they take a while to appear. Such is the case with GLP-1 drugs, which ...
Alopecia areata causes hair loss on the scalp or other body parts such as the eyebrows. New treatments like Olumiant offer hope for some people. This FDA-approved medicine works in unique ways to help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results